IPO

Nov 8, 2021

German MDx Firm Mainz Biomed Raises $10M in IPO, Begins Trading on Nasdaq

Nov 4, 2021

MDxHealth Prices IPO of American Depositary Shares

Oct 14, 2021

Lucid Diagnostics Prices $70M IPO, Starts Trading on Nasdaq

Oct 13, 2021

MDxHealth Files for IPO of American Depositary Shares

Oct 5, 2021

Genetic Analysis Raises $6.8M in Oversubscribed IPO

Sep 14, 2021

Ginkgo Bioworks to Go Public With $1.63B in Proceeds From SPAC Merger

Sep 2, 2021

Cue Health Files for IPO for up to $100M

Sep 1, 2021

MDxHealth Files for IPO of American Depositary Shares

Jul 23, 2021

Sophia Genetics Raises $234M in IPO, Eyes Additional Partnerships

Jul 19, 2021

Sophia Genetics Increases IPO Target to $221M

Jul 14, 2021

Sera Prognostics Goes Public With $75M IPO

Jul 8, 2021

Lumos Diagnostics Raises $46.9M in Australian IPO

Jul 6, 2021

Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare

Jun 30, 2021

Even as Testing Demand Started to Wane, COVID-19 Drove IPOs in Dx Space in H1 2021
Premium

Apr 28, 2021

Post-IPO, Talis Biomedical Looks Toward Expanding Infectious Disease Test Portfolio
Premium

Mar 12, 2021

Prometheus Biosciences Prices Upsized $190M IPO

Feb 18, 2021

Cancer Screening Test Developer New Horizon Health Goes Public in Hong Kong

Feb 18, 2021

Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO

Feb 5, 2021

At-Home Infectious Disease Test Developer Lucira Health Goes Public at $17 Per Share

Jan 28, 2021

Ortho Clinical Diagnostics Prices $1.29B IPO